J Rhinol.  2024 Mar;31(1):8-16. 10.18787/jr.2024.00007.

Does Desmopressin Reduce Intraoperative Bleeding in Patients Who Undergo Nasal Surgery? A Systematic Review and Meta-Analysis

Affiliations
  • 1Department of Otolaryngology-Head and Neck Surgery, Bucheon Saint Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
  • 2Department of Otolaryngology-Head and Neck Surgery, Seoul Saint Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

Abstract

Background and Objectives
This study aimed to determine the efficacy of prophylactic desmopressin administered via the intranasal or intravenous route in reducing intraoperative bleeding during nasal surgery. We conducted a meta-analysis of the relevant literature to investigate the role of preoperative desmopressin in minimizing bleeding complications associated with nasal surgery.
Methods
We screened the relevant literature published before February 2023. Nine articles that compared the perioperative use of desmopressin (treatment) with a placebo or no treatment (control) were included. The analyzed outcomes were intraoperative bleeding during nasal surgery and postoperative morbidity.
Results
The treatment group showed significant improvements in intraoperative bleeding, the surgical field, and surgeon satisfaction compared to the control group. However, the prophylactic use of desmopressin was associated with elevated blood pressure and decreased serum sodium levels compared to the control group. Nonetheless, no significant adverse effects were reported in the included studies. Subgroup analyses comparing the route of administration (intravenous vs. intranasal) and type of surgery (rhinoplasty vs. endoscopic sinus surgery) showed that desmopressin had a beneficial effect on intraoperative bleeding and the surgical field, regardless of the route of administration or type of surgery.
Conclusion
The prophylactic use of desmopressin for nasal surgery effectively reduced intraoperative bleeding, improved the surgical field, and increased surgeon satisfaction, with no significant adverse effects. However, caution should be exercised when administering desmopressin as it may cause an elevation in postoperative blood pressure in patients with cardiopulmonary problems.

Keyword

Deamino arginine vasopressin; Endoscopes; Nose; Hemorrhage; Meta-analysis

Figure

  • Fig. 1. Study selection diagram.

  • Fig. 2. Preoperative administration of desmopressin versus placebo: standard mean difference in intraoperative bleeding. TE, treatment effect; seTE, standard error of treatment effect; SMD, standardized mean difference; CI, confidence interval.

  • Fig. 3. Preoperative administration of desmopressin versus placebo: standard mean difference in the quality of the operative field. TE, treatment effect; seTE, standard error of treatment effect; SMD, standardized mean difference; CI, confidence interval.

  • Fig. 4. Preoperative administration of desmopressin versus placebo: standard mean difference in surgeon satisfaction. TE, treatment effect; seTE, standard error of treatment effect; SMD, standardized mean difference; CI, confidence interval.

  • Fig. 5. Preoperative administration of desmopressin versus placebo: standard mean difference in operative time. TE, treatment effect; seTE, standard error of treatment effect; SMD, standardized mean difference; CI, confidence interval.

  • Fig. 6. Preoperative administration of desmopressin versus placebo: standard mean difference in intraoperative arterial blood pressure. TE, treatment effect; seTE, standard error of treatment effect; SMD, standardized mean difference; CI, confidence interval.

  • Fig. 7. Preoperative administration of desmopressin versus placebo: standard mean difference in postoperative serum sodium levels. TE, treatment effect; seTE, standard error of treatment effect; SMD, standardized mean difference; CI, confidence interval.


Reference

References

1. Kelly EA, Gollapudy S, Riess ML, Woehlck HJ, Loehrl TA, Poetker DM. Quality of surgical field during endoscopic sinus surgery: a systematic literature review of the effect of total intravenous compared to inhalational anesthesia. Int Forum Allergy Rhinol. 2013; 3(6):474–81.
Article
2. Nowak S, Ołdak A, Kluzik A, Drobnik L. Impact of controlled induced hypotension on cognitive functions of patients undergoing functional endoscopic sinus surgery. Med Sci Monit. 2016; 22:898–907.
Article
3. Choudhary P, Dutta A, Sethi N, Sood J, Rai D, Gupta M. Pre-induction fentanyl dose-finding study for controlled hypotension during functional endoscopic sinus surgery. Indian J Anaesth. 2019; 63(8):653–9.
Article
4. Desborough MJ, Oakland K, Brierley C, Bennett S, Doree C, Trivella M, et al. Desmopressin use for minimising perioperative blood transfusion. Cochrane Database Syst Rev. 2017; 7(7):CD001884.
Article
5. Loomans JI, Kruip MJHA, Carcao M, Jackson S, van Velzen AS, Peters M, et al. Desmopressin in moderate hemophilia A patients: a treatment worth considering. Haematologica. 2018; 103(3):550–7.
Article
6. Kim DH, Kim SW, Basurrah MA, Hwang SH. Clinical and laboratory features of various criteria of eosinophilic chronic rhinosinusitis: a systematic review and meta-analysis. Clin Exp Otorhinolaryngol. 2022; 15(3):230–46.
Article
7. Shao H, Kuang LT, Hou WJ, Zhang T. Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiol. 2015; 15:53.
Article
8. Jahanshahi J, Tayebi E, Hashemian F, Bakhshaei MH, Ahmadi MS, Seif Rabiei MA. Effect of local desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery in patients with chronic rhinosinusitis: a triple-blinded clinical trial. Eur Arch Otorhinolaryngol. 2019; 276(7):1995–9.
Article
9. Haddady-Abianeh S, Rajabpour AA, Sanatkarfar M, Farahvash MR, Khorasani G, Molaei H. The hemostatic effect of desmopressin on bleeding as a nasal spray in open septorhinoplasty. Aesthetic Plast Surg. 2019; 43(6):1603–6.
Article
10. Youssefy A, Ghabasiah A, Heidari F, Alvandi S, Bastaninezhad S, Hosseini J, et al. The effect of desmopressin intraoperatively on hemorrhage during the rhinoplasty surgery. Indian J Otolaryngol Head Neck Surg. 2022; 74(Suppl 3):4761–5.
Article
11. Haddady-Abianeh S, Rahmati J, Delavari C, Molaei H. Comparison of the effect of injectable tranexamic acid and inhaled desmopressin in controlling bleeding and ecchymosis in open rhinoplasty. World J Plast Surg. 2022; 11(3):24–7.
Article
12. Alrajhi AA, Alghamdi AS, Baali MH, Altowairqi AF, Khan MF, Alharthi AS, et al. Efficacy of prophylactic pre-operative desmopressin administration during functional endoscopic sinus surgery for chronic rhinosinusitis: a systematic review and meta-analysis of randomised placebo-controlled trials. Clin Otolaryngol. 2023; 48(2):139–50.
Article
13. Hajimohamadi F, Hosseini J, Heidari F, Alvandi S, Bastaninezhad S, Ghabasiah A, et al. Desmopressin effects on bleeding during functional endoscopic sinus surgery on patients with chronic rhinosinusitis. Am J Otolaryngol. 2021; 42(5):103024.
Article
14. Safaeian R, Hassani V, Ghandi A, Mohseni M. Desmopressin nasal spray reduces blood loss and improves the quality of the surgical field during functional endoscopic sinus surgery. J Anaesthesiol Clin Pharmacol. 2021; 37(2):261–5.
Article
15. Akbarpour M, Jalali MM, Akbari M, Haddadi S, Fani G. Effect of desmopressin on bleeding during endoscopic sinus surgery: a randomized clinical trial. Laryngoscope Investig Otolaryngol. 2022; 7(4):920–7.
Article
16. Li J, Li G, Chen L, Li P, Zhang Y. The effect of desmopressin acetate on FESS. Modern Prev Med. 2011; 38(15):3114–7.
17. Ghadimi K, Levy JH, Welsby IJ. Perioperative management of the bleeding patient. Br J Anaesth. 2016; 117(suppl 3):iii18–30.
Article
18. Kalot MA, Husainat N, El Alayli A, Abughanimeh O, Diab O, Tayiem S, et al. von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis. Blood Adv. 2022; 6(1):62–71.
Article
19. Franchini M. The use of desmopressin as a hemostatic agent: a concise review. Am J Hematol. 2007; 82(8):731–5.
Article
20. Barinsky GL, Buziashvili D, Svider PF, Carron MA, Folbe AJ, Hsueh WD, et al. Perioperative desmopressin for patients undergoing otolaryngologic procedures: a systematic review. Otolaryngol Head Neck Surg. 2019; 161(1):36–45.
Article
Full Text Links
  • JR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr